217 related articles for article (PubMed ID: 38746323)
1. The CTLH Ubiquitin Ligase Substrates ZMYND19 and MKLN1 Negatively Regulate mTORC1 at the Lysosomal Membrane.
Wang Y; Guo R; Piedras BI; Tang HY; Asara JM; Tempera I; Lieberman PM; Gewurz BE
Res Sq; 2024 Apr; ():. PubMed ID: 38746323
[TBL] [Abstract][Full Text] [Related]
2. The mammalian CTLH complex is an E3 ubiquitin ligase that targets its subunit muskelin for degradation.
Maitland MER; Onea G; Chiasson CA; Wang X; Ma J; Moor SE; Barber KR; Lajoie GA; Shaw GS; Schild-Poulter C
Sci Rep; 2019 Jul; 9(1):9864. PubMed ID: 31285494
[TBL] [Abstract][Full Text] [Related]
3. Non-canonical substrate recognition by the human WDR26-CTLH E3 ligase regulates prodrug metabolism.
Gottemukkala KV; Chrustowicz J; Sherpa D; Sepic S; Vu DT; Karayel Ö; Papadopoulou EC; Gross A; Schorpp K; von Gronau S; Hadian K; Murray PJ; Mann M; Schulman BA; Alpi AF
Mol Cell; 2024 May; 84(10):1948-1963.e11. PubMed ID: 38759627
[TBL] [Abstract][Full Text] [Related]
4. Molecular phylogeny of a RING E3 ubiquitin ligase, conserved in eukaryotic cells and dominated by homologous components, the muskelin/RanBPM/CTLH complex.
Francis O; Han F; Adams JC
PLoS One; 2013; 8(10):e75217. PubMed ID: 24143168
[TBL] [Abstract][Full Text] [Related]
5. The CTLH Complex in Cancer Cell Plasticity.
Huffman N; Palmieri D; Coppola V
J Oncol; 2019; 2019():4216750. PubMed ID: 31885576
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of ubiquitination substrates reveals a CTLH E3 ligase complex-dependent regulation of glycolysis.
Maitland MER; Kuljanin M; Wang X; Lajoie GA; Schild-Poulter C
FASEB J; 2021 Sep; 35(9):e21825. PubMed ID: 34383978
[TBL] [Abstract][Full Text] [Related]
7. Structural and Functional Insights into GID/CTLH E3 Ligase Complexes.
Maitland MER; Lajoie GA; Shaw GS; Schild-Poulter C
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682545
[TBL] [Abstract][Full Text] [Related]
8. Modular UBE2H-CTLH E2-E3 complexes regulate erythroid maturation.
Sherpa D; Mueller J; Karayel Ö; Xu P; Yao Y; Chrustowicz J; Gottemukkala KV; Baumann C; Gross A; Czarnecki O; Zhang W; Gu J; Nilvebrant J; Sidhu SS; Murray PJ; Mann M; Weiss MJ; Schulman BA; Alpi AF
Elife; 2022 Dec; 11():. PubMed ID: 36459484
[TBL] [Abstract][Full Text] [Related]
9. Identifying E3 Ligase Substrates With Quantitative Degradation Proteomics.
Jordan VN; Ordureau A; An H
Chembiochem; 2023 Aug; 24(16):e202300108. PubMed ID: 37166757
[TBL] [Abstract][Full Text] [Related]
10. Distinct nuclear and cytoplasmic assemblies and interactomes of the mammalian CTLH E3 ligase complex.
Onea G; Maitland MER; Wang X; Lajoie GA; Schild-Poulter C
J Cell Sci; 2022 Jul; 135(14):. PubMed ID: 35833506
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide screen of
Simwela NV; Johnston L; Pavinski Bitar P; Jaecklein E; Altier C; Sassetti CM; Russell DG
bioRxiv; 2024 May; ():. PubMed ID: 38766174
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of HDAC6 activity through interaction with RanBPM and its associated CTLH complex.
Salemi LM; Maitland MER; Yefet ER; Schild-Poulter C
BMC Cancer; 2017 Jul; 17(1):460. PubMed ID: 28668087
[TBL] [Abstract][Full Text] [Related]
13. Skraban-Deardorff intellectual disability syndrome-associated mutations in WDR26 impair CTLH E3 complex assembly.
Gross A; Müller J; Chrustowicz J; Strasser A; Gottemukkala KV; Sherpa D; Schulman BA; Murray PJ; Alpi AF
FEBS Lett; 2024 May; 598(9):978-994. PubMed ID: 38575527
[TBL] [Abstract][Full Text] [Related]
14. Regulation of c-Raf Stability through the CTLH Complex.
McTavish CJ; Bérubé-Janzen W; Wang X; Maitland MER; Salemi LM; Hess DA; Schild-Poulter C
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30795516
[TBL] [Abstract][Full Text] [Related]
15. The multi-subunit GID/CTLH E3 ubiquitin ligase promotes cell proliferation and targets the transcription factor Hbp1 for degradation.
Lampert F; Stafa D; Goga A; Soste MV; Gilberto S; Olieric N; Picotti P; Stoffel M; Peter M
Elife; 2018 Jun; 7():. PubMed ID: 29911972
[TBL] [Abstract][Full Text] [Related]
16. Cell signalling pathway regulation by RanBPM: molecular insights and disease implications.
Salemi LM; Maitland MER; McTavish CJ; Schild-Poulter C
Open Biol; 2017 Jun; 7(6):. PubMed ID: 28659384
[TBL] [Abstract][Full Text] [Related]
17. The E3 ubiquitin ligase protein associated with Myc (Pam) regulates mammalian/mechanistic target of rapamycin complex 1 (mTORC1) signaling in vivo through N- and C-terminal domains.
Han S; Kim S; Bahl S; Li L; Burande CF; Smith N; James M; Beauchamp RL; Bhide P; DiAntonio A; Ramesh V
J Biol Chem; 2012 Aug; 287(36):30063-72. PubMed ID: 22798074
[TBL] [Abstract][Full Text] [Related]
18. RanBP9 controls the oligomeric state of CTLH complex assemblies.
van Gen Hassend PM; Pottikkadavath A; Delto C; Kuhn M; Endres M; Schönemann L; Schindelin H
J Biol Chem; 2023 Feb; 299(2):102869. PubMed ID: 36621627
[TBL] [Abstract][Full Text] [Related]
19. mTORC1 signaling requires proteasomal function and the involvement of CUL4-DDB1 ubiquitin E3 ligase.
Ghosh P; Wu M; Zhang H; Sun H
Cell Cycle; 2008 Feb; 7(3):373-81. PubMed ID: 18235224
[TBL] [Abstract][Full Text] [Related]
20. The GID ubiquitin ligase complex is a regulator of AMPK activity and organismal lifespan.
Liu H; Ding J; Köhnlein K; Urban N; Ori A; Villavicencio-Lorini P; Walentek P; Klotz LO; Hollemann T; Pfirrmann T
Autophagy; 2020 Sep; 16(9):1618-1634. PubMed ID: 31795790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
